145 related articles for article (PubMed ID: 33120800)
1. Why recurrence was initially suspected during colorectal cancer postoperative surveillance?: A retrospective analysis.
Hung H; You J; Chiang J; Hsieh P; Chiang S; Lai C; Tasi W; Yeh C
Medicine (Baltimore); 2020 Oct; 99(43):e22803. PubMed ID: 33120800
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
3. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
6. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
[TBL] [Abstract][Full Text] [Related]
7. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
8. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
Su BB; Shi H; Wan J
World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level.
Tobaruela E; Enriquez JM; Diez M; Camunas J; Muguerza J; Granell J
Int J Biol Markers; 1997; 12(1):18-21. PubMed ID: 9176713
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
Huang SH; Tsai WS; You JF; Hung HY; Yeh CY; Hsieh PS; Chiang SF; Lai CC; Chiang JM; Tang R; Chen JS
Ann Surg Oncol; 2019 Jun; 26(6):1685-1694. PubMed ID: 30915591
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Huh JW; Kim CH; Lim SW; Kim HR; Kim YJ
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1449-55. PubMed ID: 23765330
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F
Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
[TBL] [Abstract][Full Text] [Related]
16. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
Pakdel A; Malekzadeh M; Naghibalhossaini F
Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
[TBL] [Abstract][Full Text] [Related]
17. Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern.
Nozawa H; Yokota Y; Emoto S; Yokoyama Y; Sasaki K; Murono K; Abe S; Sonoda H; Shinagawa T; Ishihara S
Ann Med; 2023; 55(2):2246997. PubMed ID: 37963211
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
19. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
20. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.
Choi JS; Min JS
Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
